Which patent estates did apotex's ruxolitinib anda in usa challenge?

Which patent estates did Apotex challenge for its ruxolitinib ANDA in the US?

The provided information does not include the list of patent estates (or the specific patents) that Apotex’s ruxolitinib ANDA in the USA challenged. Without the case record or Apotex filing details, I can’t accurately identify which “patent estates” were at issue.

What you’d need to identify the exact patent estates

To answer precisely, I’d need at least one of the following from the public record:
- The Orange Book entry for ruxolitinib and the “patent estates” tied to the listed NDA(s)
- The specific paragraph IV notice (or the complaint/answer) showing which patents Apotex alleged were infringed/not infringed/invalid
- The docket/court document where the challenged patents are enumerated

Share the source and I’ll extract the challenged estates

If you paste a link or text from the Apotex notice, complaint, or the relevant court docket (or tell me the NDA/brand name and the court/case number), I can list the exact patent estates Apotex challenged.